+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Human Liver Models Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • February 2022
  • Region: Global
  • TechNavio
  • ID: 5553840
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publishers market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth. The publisher has been monitoring the human liver models market and it is poised to grow by $ 1.91 bn during 2022-2026, decelerating at a CAGR of 12.94% during the forecast period. This report on human liver models market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven Increasing prevalence of liver diseases, new drug approvals, and advancements in diagnostic methods. In addition, increasing prevalence of liver diseases is anticipated to boost the growth of the market as well.

The human liver models market analysis includes the type segment and geographic landscape.

The publisher's human liver models market is segmented as below:


By Type


  • Liver organoids
  • Liver-on-a-chip
  • 2D models
  • 3D bioprinting

By Geographical Landscape


  • North America
  • Europe
  • APAC
  • Middle East and Africa
  • South America

This study identifies the technological advancements in the human organ model as one of the prime reasons driving the human liver models market growth during the next few years. Also, increase in collaborations for liver cancer drug development and robust r and d activities will lead to sizable demand in the market.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report on human liver models market covers the following areas:
  • Human liver models market sizing
  • Human liver models market forecast
  • Human liver models market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human liver models market vendors that include BioIVT LLC, CELLINK AB, CN Bio Innovations Ltd., Corning Inc., Cyfuse Biomedical K.K., Emulate Inc., H. L. Scientific, Hangzhou Jienuofei Biotechnology Co. Ltd., InSphero AG, Kirkstall Ltd., LifeSpan BioSciences Inc., MIMETAS BV, N. C. KANSIL and SONS, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and Western Surgical. Also, the human liver models market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Liver organoids - Market size and forecast 2021-2026
Exhibit 28: Chart on Liver organoids - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Liver organoids - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Liver organoids - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Liver organoids - Year-over-year growth 2021-2026 (%)
5.4 Liver-on-a-chip - Market size and forecast 2021-2026
Exhibit 32: Chart on Liver-on-a-chip - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Liver-on-a-chip - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Liver-on-a-chip - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Liver-on-a-chip - Year-over-year growth 2021-2026 (%)
5.5 2D models - Market size and forecast 2021-2026
Exhibit 36: Chart on 2D models - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on 2D models - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on 2D models - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on 2D models - Year-over-year growth 2021-2026 (%)
5.6 3D bioprinting - Market size and forecast 2021-2026
Exhibit 40: Chart on 3D bioprinting - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on 3D bioprinting - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on 3D bioprinting - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on 3D bioprinting - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Type
Exhibit 44: Market opportunity by Type ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 APAC - Market size and forecast 2021-2026
Exhibit 58: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on APAC - Year-over-year growth 2021-2026 (%)
7.6 Middle East and Africa - Market size and forecast 2021-2026
Exhibit 62: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
7.7 South America - Market size and forecast 2021-2026
Exhibit 66: Chart on South America - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on South America - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on South America - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on South America - Year-over-year growth 2021-2026 (%)
7.8 US - Market size and forecast 2021-2026
Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
7.9 Germany - Market size and forecast 2021-2026
Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 China - Market size and forecast 2021-2026
Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
7.12 Japan - Market size and forecast 2021-2026
Exhibit 86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 88: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.13 Market opportunity By Geographical Landscape
Exhibit 90: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 91: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 93: Overview on factors of disruption
9.4 Industry risks
Exhibit 94: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 95: Vendors covered
10.2 Market positioning of vendors
Exhibit 96: Matrix on vendor position and classification
10.3 BioIVT LLC
Exhibit 97: BioIVT LLC - Overview
Exhibit 98: BioIVT LLC - Product / Service
Exhibit 99: BioIVT LLC - Key news
Exhibit 100: BioIVT LLC - Key offerings
10.4 CELLINK AB
Exhibit 101: CELLINK AB - Overview
Exhibit 102: CELLINK AB - Business segments
Exhibit 103: CELLINK AB - Key offerings
Exhibit 104: CELLINK AB - Segment focus
10.5 CN Bio Innovations Ltd.
Exhibit 105: CN Bio Innovations Ltd. - Overview
Exhibit 106: CN Bio Innovations Ltd. - Product / Service
Exhibit 107: CN Bio Innovations Ltd. - Key offerings
10.6 Corning Inc.
Exhibit 108: Corning Inc. - Overview
Exhibit 109: Corning Inc. - Business segments
Exhibit 110: Corning Inc. - Key offerings
Exhibit 111: Corning Inc. - Segment focus
10.7 Cyfuse Biomedical K.K.
Exhibit 112: Cyfuse Biomedical K.K. - Overview
Exhibit 113: Cyfuse Biomedical K.K. - Product / Service
Exhibit 114: Cyfuse Biomedical K.K. - Key offerings
10.8 Emulate Inc.
Exhibit 115: Emulate Inc. - Overview
Exhibit 116: Emulate Inc. - Product / Service
Exhibit 117: Emulate Inc. - Key offerings
10.9 Hangzhou Jienuofei Biotechnology Co. Ltd.
Exhibit 118: Hangzhou Jienuofei Biotechnology Co. Ltd. - Overview
Exhibit 119: Hangzhou Jienuofei Biotechnology Co. Ltd. - Product / Service
Exhibit 120: Hangzhou Jienuofei Biotechnology Co. Ltd. - Key offerings
10.10 InSphero AG
Exhibit 121: InSphero AG - Overview
Exhibit 122: InSphero AG - Product / Service
Exhibit 123: InSphero AG - Key news
Exhibit 124: InSphero AG - Key offerings
10.11 MIMETAS BV
Exhibit 125: MIMETAS BV - Overview
Exhibit 126: MIMETAS BV - Product / Service
Exhibit 127: MIMETAS BV - Key offerings
10.12 Organovo Holdings Inc.
Exhibit 128: Organovo Holdings Inc. - Overview
Exhibit 129: Organovo Holdings Inc. - Business segments
Exhibit 130: Organovo Holdings Inc. - Key offerings
Exhibit 131: Organovo Holdings Inc. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 132: Inclusions checklist
Exhibit 133: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 134: Currency conversion rates for US$
11.4 Research methodology
Exhibit 135: Research methodology
Exhibit 136: Validation techniques employed for market sizing
Exhibit 137: Information sources
11.5 List of abbreviations
Exhibit 138: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Type - Market share 2021-2026 (%)
Exhibits 25: Data Table on Type - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Type
Exhibits 27: Data Table on Comparison by Type
Exhibits 28: Chart on Liver organoids - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Liver organoids - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Liver organoids - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Liver organoids - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Liver-on-a-chip - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Liver-on-a-chip - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Liver-on-a-chip - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Liver-on-a-chip - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on 2D models - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on 2D models - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on 2D models - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on 2D models - Year-over-year growth 2021-2026 (%)
Exhibits 40: Chart on 3D bioprinting - Market size and forecast 2021-2026 ($ million)
Exhibits 41: Data Table on 3D bioprinting - Market size and forecast 2021-2026 ($ million)
Exhibits 42: Chart on 3D bioprinting - Year-over-year growth 2021-2026 (%)
Exhibits 43: Data Table on 3D bioprinting - Year-over-year growth 2021-2026 (%)
Exhibits 44: Market opportunity by Type ($ million)
Exhibits 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 48: Chart on Geographic comparison
Exhibits 49: Data Table on Geographic comparison
Exhibits 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on APAC - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on South America - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on South America - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on South America - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on South America - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 88: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 90: Market opportunity By Geographical Landscape ($ million)
Exhibits 91: Impact of drivers and challenges in 2021 and 2026
Exhibits 92: Overview on Criticality of inputs and Factors of differentiation
Exhibits 93: Overview on factors of disruption
Exhibits 94: Impact of key risks on business
Exhibits 95: Vendors covered
Exhibits 96: Matrix on vendor position and classification
Exhibits 97: BioIVT LLC - Overview
Exhibits 98: BioIVT LLC - Product / Service
Exhibits 99: BioIVT LLC - Key news
Exhibits 100: BioIVT LLC - Key offerings
Exhibits 101: CELLINK AB - Overview
Exhibits 102: CELLINK AB - Business segments
Exhibits 103: CELLINK AB - Key offerings
Exhibits 104: CELLINK AB - Segment focus
Exhibits 105: CN Bio Innovations Ltd. - Overview
Exhibits 106: CN Bio Innovations Ltd. - Product / Service
Exhibits 107: CN Bio Innovations Ltd. - Key offerings
Exhibits 108: Corning Inc. - Overview
Exhibits 109: Corning Inc. - Business segments
Exhibits 110: Corning Inc. - Key offerings
Exhibits 111: Corning Inc. - Segment focus
Exhibits 112: Cyfuse Biomedical K.K. - Overview
Exhibits 113: Cyfuse Biomedical K.K. - Product / Service
Exhibits 114: Cyfuse Biomedical K.K. - Key offerings
Exhibits 115: Emulate Inc. - Overview
Exhibits 116: Emulate Inc. - Product / Service
Exhibits 117: Emulate Inc. - Key offerings
Exhibits 118: Hangzhou Jienuofei Biotechnology Co. Ltd. - Overview
Exhibits 119: Hangzhou Jienuofei Biotechnology Co. Ltd. - Product / Service
Exhibits 120: Hangzhou Jienuofei Biotechnology Co. Ltd. - Key offerings
Exhibits 121: InSphero AG - Overview
Exhibits 122: InSphero AG - Product / Service
Exhibits 123: InSphero AG - Key news
Exhibits 124: InSphero AG - Key offerings
Exhibits 125: MIMETAS BV - Overview
Exhibits 126: MIMETAS BV - Product / Service
Exhibits 127: MIMETAS BV - Key offerings
Exhibits 128: Organovo Holdings Inc. - Overview
Exhibits 129: Organovo Holdings Inc. - Business segments
Exhibits 130: Organovo Holdings Inc. - Key offerings
Exhibits 131: Organovo Holdings Inc. - Segment focus
Exhibits 132: Inclusions checklist
Exhibits 133: Exclusions checklist
Exhibits 134: Currency conversion rates for US$
Exhibits 135: Research methodology
Exhibits 136: Validation techniques employed for market sizing
Exhibits 137: Information sources
Exhibits 138: List of abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BioIVT LLC
  • CELLINK AB
  • CN Bio Innovations Ltd.
  • Corning Inc.
  • Cyfuse Biomedical K.K.
  • Emulate Inc.
  • H. L. Scientific
  • Hangzhou Jienuofei Biotechnology Co. Ltd.
  • InSphero AG
  • Kirkstall Ltd.
  • LifeSpan BioSciences Inc.
  • MIMETAS BV
  • N. C. KANSIL and SONS
  • Organovo Holdings Inc.
  • Pandorum Technologies Pvt. Ltd.
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • Western Surgical